MedPath

Effects of CBD on 2 Mile Run Time Trial Performance

Not Applicable
Active, not recruiting
Conditions
Healthy
Interventions
Dietary Supplement: Cannabidiol Capsules
Registration Number
NCT06364254
Lead Sponsor
University of Northern Colorado
Brief Summary

Individuals who engage in endurance events tend to experience higher levels of stress within the body, mind, and gut, that often lead to impairment of performance. Based on previous studies, CBD has the potential relieve gut distress, and reduce pre-race anxiety thus resulting in an improvement in sport performance. Given the current research on the use of CBD in active individuals, the aim of this pilot study is to explore the effects of CBD compared to a placebo on anxiety, GI distress and a 2-mile running performance in a moderately active population identifying as female.

Detailed Description

This study will recruit moderately active, healthy individuals (N=30) who identify as female between the ages of 18-40 years who have some running experience and are running at least 2 miles, 2 times per week. This will be a cross over study, so each participant will be their own control, receiving either the placebo and CBD on two separate occasions. The females recruited will report to the Exercise Physiology lab in Gunter Hall on the University of Northern Colorado's campus for testing a total of two times.

The first visit will include initial paperwork such as the informed consent, physical activity readiness questionnaire (PARQ), Menstrual Cycle Questionnaire and a screening to determine current activity levels, uses CBD, THC and any other legal drugs/medications. This first interaction allows study staff to ensure that qualify to take part in the study.

After informed consent is obtained, the participant will be given either the placebo or CBD capsule with a controlled higher fat food (88 Acres protein bar) 2 hours before the testing protocol along. Once the CBD capsule or placebo is taken, participants will complete caffeine consumption, exercise and running questionnaires which will be administered on a tablet with study staff after 1.5 hours or waiting.

During the first visit, individuals will stay for a standardized period (2 hours) before doing a urine analysis to determine hydration status and taking v lactate, and heart rate variability. Current anxiety symptoms will also be evaluated

Once baseline measurements obtained, individuals will then be instructed to run 2 miles a treadmill as fast as possible. Lactate will be monitored three times during the test (.50 mile mark, halfway point (1 mile) and just before finishing the time trial run at the 1.98 mile mark). All participants will be taken through a 30-minute cool down period walking 2.5 mph on the treadmill while having lactate measured every 5, 10, 15, and 30 minutes post finishing. Finish time, GI distress questionnaire, and overall feelings will be recorded post finish of the 2 mile time trial.

Participants will be given a 25-30 day time between visits 1 and 2 to ensure exercise during the same menstrual cycle phase (hormone cycle) for those that are cycling. During the second and final visit, participants will undergo the same procedure, however, will be given the opposite oral administration from the first visit (either placebo or CBD).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Running at least 2 miles 2 times per week.
Exclusion Criteria
  • Current diagnosis of a chronic disease or serious mental health disorder.
  • Current or use of cannabis or cannabis products within the past 4 weeks
  • Currently in perimenopause or menopause, transgender female not undergoing hormone treatment (estrogen)
  • Having any underlying health concerns or have any current injuries that can be worsened with exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CannabidiolCannabidiol CapsulesCannabidiol capsules 2 hours prior to 2 mile run.
PlaceboCannabidiol CapsulesPlacebo capsules 2 hours prior to 2 mile run.
Primary Outcome Measures
NameTimeMethod
Difference in Time Trial Times10-25 minutes

Time to run 2 miles on an indoor treadmill

Difference in Anxiety Measured with the State Trait Anxiety Inventory5 minutes

This questionnaire will be administered just before each run to assess the individual's current anxiety symptoms.The State-Trait Anxiety Inventory (STAI) consists of 20 items aimed at evaluating trait anxiety and 20 for state anxiety. All items are rated on a 4-point scale (e.g., from "Not at all" to "Very much so"). Higher scores suggest elevated anxiety.

Different in Heart Rate Variability5 minutes

The root mean square successive difference method will be used with the 10 second electrocardiogram reading. Higher heart rate variability is associated with better health.

Difference in Blood Lactate Concentrations45 minutes

Blood lactate will be measured just before the time trial, 3 minutes after the start of the run, after 1 mile and 1.98 miles of running and after 5, 10, 15, and 30 minutes of walking recovery. Higher lactate concentrations are associated with more effort during exercise and a slower recovery from exercise.

Difference in Gastrointestinal Distress5 minutes

This questionnaire consists of 12 questions related to distress symptoms. Responses are absent, mild, moderate, severe. The higher the score, the more GI distress is present. This assessment will be completed after the 2 mile run.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Of Northern Colorado

🇺🇸

Greeley, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath